Skip to menu Skip to content Skip to footer

2010

Journal Article

Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection

McWhinney, Brett C., Wallis, Steven C., Hillister, Tara, Roberts, Jason A., Lipman, Jeffrey and Ungerer, Jacobus P.J. (2010). Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878 (22), 2039-2043. doi: 10.1016/j.jchromb.2010.05.027

Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection

2010

Journal Article

Optimizing antibiotic use in the intensive care unit

Ulldemolins, Marta, Roberts, Jason A. and Lipman, Jeffrey (2010). Optimizing antibiotic use in the intensive care unit. Clinical Pulmonary Medicine, 17 (4), 162-169. doi: 10.1097/CPM.0b013e3181e47953

Optimizing antibiotic use in the intensive care unit

2010

Journal Article

Augmented renal clearance in the Intensive Care Unit: An illustrative case series

Udy, Andrew A., Putt, Michael T., Shanmugathasan, Sulochana, Roberts, Jason A. and Lipman, Jeffrey (2010). Augmented renal clearance in the Intensive Care Unit: An illustrative case series. International Journal of Antimicrobial Agents, 35 (6), 606-608. doi: 10.1016/j.ijantimicag.2010.02.013

Augmented renal clearance in the Intensive Care Unit: An illustrative case series

2010

Journal Article

Meropenem: Focus on its use in serious bacterial infections

Roberts, Jason A., Ulldemolins, Marta and Lipman, Jeffrey (2010). Meropenem: Focus on its use in serious bacterial infections. Clinical Medicine Reviews in Therapeutics, 2, 1-14. doi: 10.4137/CMRT.S4598

Meropenem: Focus on its use in serious bacterial infections

2010

Journal Article

Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?

Roberts, Jason A., Hope, William W. and Lipman, Jeffrey (2010). Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?. International Journal of Antimicrobial Agents, 35 (5), 419-420. doi: 10.1016/j.ijantimicag.2010.01.022

Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?

2010

Journal Article

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

Roberts, Jason A., Kirkpatrick, Carl M. J., Roberts, Michael S., Dalley, Andrew J. and Lipman, Jeffrey (2010). First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. International Journal of Antimicrobial Agents, 35 (2), 156-163. doi: 10.1016/j.ijantimicag.2009.10.008

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

2010

Journal Article

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

Martin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24.

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

2010

Journal Article

Augmented renal clearance: Implications for antibacterial dosing in the critically Ill

Udy, Andrew A., Roberts, Jason A., Boots, Robert J., Paterson, David L. and Lipman, Jeffrey (2010). Augmented renal clearance: Implications for antibacterial dosing in the critically Ill. Clinical Pharmacokinetics, 49 (1), 1-16. doi: 10.2165/11318140-000000000-00000

Augmented renal clearance: Implications for antibacterial dosing in the critically Ill

2009

Journal Article

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

Ranganathan, Dwarakanathan, Varghese, Julie M., Fassett, Robert G., Lipman, Jeffrey, D'Intini, Vincent, Healy, Helen and Roberts, Jason A. (2009). Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study. BMC Nephrology, 10 (1) 42, 1-6. doi: 10.1186/1471-2369-10-42

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

2009

Journal Article

Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis

Roberts, Jason A., Udy, Andrew A., O'Donoghue, Stephen, Briscoe, Scott, Paterson, David L. and Lipman, Jeffrey (2009). Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis. International Journal of Antimicrobial Agents, 34 (4), 383-384. doi: 10.1016/j.ijantimicag.2009.05.005

Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis

2009

Journal Article

Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing

Roberts, JA and Lipman, J (2009). Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing. Journal of Pharmacy Practice and Research, 39 (3), 219-222. doi: 10.1002/j.2055-2335.2009.tb00457.x

Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing

2009

Journal Article

Midazolam metabolism: Implications for individualised dosing?

Roberts, Jason A., Coulthard, Mark G., Addison, Russell S., Foot, Carole and Lipman, Jeffrey (2009). Midazolam metabolism: Implications for individualised dosing?. Journal of Pharmacy Practice and Research, 39 (3), 198-201. doi: 10.1002/j.2055-2335.2009.tb00452.x

Midazolam metabolism: Implications for individualised dosing?

2009

Journal Article

Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy

Roberts, Jason A. and Lipman, Jeffrey (2009). Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy. Critical Care Medicine, 37 (8), 2491-2492. doi: 10.1097/CCM.0b013e3181aee840

Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy

2009

Journal Article

A systematic review on clinical benefits of continuous administration of [beta]-lactam antibiotics

Roberts, Jason A., Webb, Steven, Paterson, David, Ho, Kwok M. and Lipman, Jeffrey (2009). A systematic review on clinical benefits of continuous administration of [beta]-lactam antibiotics. Critical Care Medicine, 37 (6), 2071-2078. doi: 10.1097/CCM.0b013e3181a0054d

A systematic review on clinical benefits of continuous administration of [beta]-lactam antibiotics

2009

Journal Article

Pharmacokinetic issues for antibiotics in the critically ill patient

Roberts, Jason A. and Lipman, Jeffrey (2009). Pharmacokinetic issues for antibiotics in the critically ill patient. Critical Care Medicine, 37 (3), 840-851. doi: 10.1097/CCM.0b013e3181961bff

Pharmacokinetic issues for antibiotics in the critically ill patient

2009

Journal Article

Piperacillin penetration into tissue of critically ill patients with sepsis - Bolus versus continuous administration?

Roberts, Jason A., Roberts, Michael S., Robertson, Thomas A., Dalley, Andrew J. and Lipman, Jeffrey (2009). Piperacillin penetration into tissue of critically ill patients with sepsis - Bolus versus continuous administration?. Critical Care Medicine, 37 (3), 926-933. doi: 10.1097/CCM.0b013e3181968e44

Piperacillin penetration into tissue of critically ill patients with sepsis - Bolus versus continuous administration?

2009

Journal Article

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

Roberts, Jason A., Kirkpatrick, Carl M. J., Roberts, Michael S., Robertson, Thomas A., Dalley, Andrew J. and Lipman, Jeffrey (2009). Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. Journal of Antimicrobial Chemotherapy, 64 (1), 142-150. doi: 10.1093/jac/dkp139

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

2009

Journal Article

You only find what you look for: The importance of high creatinine clearance in the critically ill

Udy, A., Roberts, J. A., Boots, R. J. and Lipman, J. (2009). You only find what you look for: The importance of high creatinine clearance in the critically ill. Anaesthesia and Intensive Care, 37 (1), 11-13. doi: 10.1177/0310057x0903700123

You only find what you look for: The importance of high creatinine clearance in the critically ill

2009

Journal Article

Effective dose from cone beam CT examinations in dentistry

Roberts, J. A., Drage, N. A., Davies, J. and Thomas, D. W. (2009). Effective dose from cone beam CT examinations in dentistry. British Journal of Radiology, 82 (973), 35-40. doi: 10.1259/bjr/31419627

Effective dose from cone beam CT examinations in dentistry

2008

Journal Article

Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?

Roberts, Jason A, Lipman, Jeffrey, Blot, Stijn and Rello, Jordi (2008). Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Current Opinion in Critical Care, 14 (4), 390-396. doi: 10.1097/MCC.0b013e3283021b3a

Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?